‘Triple-threat’ immune cells target heart-attack plaque
UCLA scientists engineered 'triple-threat' immune cells that attack artery plaques by recognising three harmful cell types, beating single-target versions.
Simple explainers on world affairs, science, health and more.
All news under one minute
UCLA scientists engineered 'triple-threat' immune cells that attack artery plaques by recognising three harmful cell types, beating single-target versions.
Reframe's survey of 763 members finds 82% join Sober October for mental or emotional well-being, but 48% of them expect stress to…
Boston Children's researchers find metabolic enzyme FAH in the nucleus of breast cancer cells, where it activates CDK9 and drives drug resistance.
The Supreme Court slammed medicine markups after noting a cancer drug's Rs 27,000 MRP vs Rs 2,700-3,000 retailer cost; asked why 16%…
Merck's tulisokibart hit HiSCR50 at 16 weeks in 72% of HS patients vs 35% on placebo; results presented at EADV 2026.
Novo Nordisk's CagriSema reduced brain response to food cues and cut weight by 22.4% in a 52-week study presented at EASD 2026…
Baylor team uses AI and proteomics to discover molecular glues that destroy VAV1, a protein linked to blood cancers.
The Netherlands has confirmed details of the first child euthanised under its expanded 2024 law allowing doctors to end the life of…
Chennai has recorded 1,775 confirmed dengue cases this month, along with more than 8,300 fever cases, Greater Chennai Corporation Commissioner G S…
Bangladesh reported 6 dengue deaths and 1,942 admissions in 24 hours to September 29. The 2026 toll is 239.